Media OutReach

Media OutReach

Berlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment

Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting […]

Kaohsiung Draws Potential Investors at Kumamoto Expo

KAOHSIUNG, TAIWAN – Media OutReach Newswire – 4 March 2024 – Headed by Deputy Mayor Lo Ta-sheng, the Kaohsiung delegation to KUMAMOTO Industrial Revitalization EXPO 2024 and for a fact-finding tour of Kyushu has wound up a hugely rewarding journey. Over the course of the two-day expo, the Kaohsiung Pavilion […]